An update in treating transformed lymphoma. Issue 3 (September 2018)
- Record Type:
- Journal Article
- Title:
- An update in treating transformed lymphoma. Issue 3 (September 2018)
- Main Title:
- An update in treating transformed lymphoma
- Authors:
- Godfrey, James
Leukam, Michael J.
Smith, Sonali M. - Abstract:
- Abstract: Indolent lymphomas typically have a prolonged course and favorable prognosis. Recent data support survival times that can reach several decades, even if periodic treatment is needed to manage symptoms or stabilize disease. However, all indolent lymphomas have the potential to undergo transformation to an aggressive phenotype, clinically characterized by a rapid progression of adenopathy, new-onset constitutional symptoms, or laboratory abnormalities, and the immediate need for therapeutic intervention. The most common scenario is transformation of follicular lymphoma to either diffuse large B-cell lymphoma or high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 translocations; however, other indolent subtypes such as marginal zone lymphoma, lymphoplasmacytic lymphoma, small lymphocytic lymphoma/chronic lymphocytic leukemia, or even nodular lymphocyte predominant Hodgkin lymphoma, can undergo similar histologic transformation. The prognosis of transformed lymphomas has historically been quite poor, but there is ample evidence this is changing in the rituximab era. This article will provide a review of transformed lymphomas with an emphasis on treatment and the nuances of diagnosis and clinical management. Unless otherwise specified, all discussion in this review pertains to transformedfollicular lymphoma which is the more common scenario and the subtype with the most robust data. In many cases, this information can be extrapolated and applied to other indolentAbstract: Indolent lymphomas typically have a prolonged course and favorable prognosis. Recent data support survival times that can reach several decades, even if periodic treatment is needed to manage symptoms or stabilize disease. However, all indolent lymphomas have the potential to undergo transformation to an aggressive phenotype, clinically characterized by a rapid progression of adenopathy, new-onset constitutional symptoms, or laboratory abnormalities, and the immediate need for therapeutic intervention. The most common scenario is transformation of follicular lymphoma to either diffuse large B-cell lymphoma or high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 translocations; however, other indolent subtypes such as marginal zone lymphoma, lymphoplasmacytic lymphoma, small lymphocytic lymphoma/chronic lymphocytic leukemia, or even nodular lymphocyte predominant Hodgkin lymphoma, can undergo similar histologic transformation. The prognosis of transformed lymphomas has historically been quite poor, but there is ample evidence this is changing in the rituximab era. This article will provide a review of transformed lymphomas with an emphasis on treatment and the nuances of diagnosis and clinical management. Unless otherwise specified, all discussion in this review pertains to transformedfollicular lymphoma which is the more common scenario and the subtype with the most robust data. In many cases, this information can be extrapolated and applied to other indolent histologies (i.e. transformed marginal zone lymphoma); however, several other clinical scenarios, such as Richter's transformation and "double hit" transformations, warrant a distinct discussion and will be reviewed separately. … (more)
- Is Part Of:
- Baillière's best practice and research in clinical haematology. Volume 31:Issue 3(2018)
- Journal:
- Baillière's best practice and research in clinical haematology
- Issue:
- Volume 31:Issue 3(2018)
- Issue Display:
- Volume 31, Issue 3 (2018)
- Year:
- 2018
- Volume:
- 31
- Issue:
- 3
- Issue Sort Value:
- 2018-0031-0003-0000
- Page Start:
- 251
- Page End:
- 261
- Publication Date:
- 2018-09
- Subjects:
- Follicular lymphoma -- Transformation -- Richter's syndrome -- Autologous transplant
Hematology -- Periodicals
Blood -- Periodicals
Hematologic Diseases -- Periodicals
Electronic journals
616 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15216926 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/15216926 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/15216926 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/fsip?dbname=eco&journal=1521-6926&screen=info&done=referer ↗
http://www.harcourt-international.com/journals ↗
http://www.idealibrary.com/links/toc/beha/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.beha.2018.07.008 ↗
- Languages:
- English
- ISSNs:
- 1521-6926
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1942.327828
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 7263.xml